Navigation Links
Masimo Reports Third Quarter 2010 Financial Results
Date:11/2/2010

IRVINE, Calif., Nov. 2, 2010 /PRNewswire-FirstCall/ --

Q3 2010 Highlights (compared to Q3 2009):

  • Total revenue rose 15.5% to $101.0 million
  • Product revenue rose 18.2% to $88.8 million
  • Masimo SET and Masimo rainbow SET unit shipments rose 43.1% to 37,500
  • Masimo rainbow revenue rose 98.7% to $11.9 million
  • GAAP EPS rose 22.7% to $0.27.  Excluding $0.01 in one-time expenses, adjusted EPS rose 27.3% to $0.28

  • Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter of 2010.

    Masimo’s total revenue for the third quarter rose 15.5% to $101.0 million, compared to $87.4 million for the third quarter of 2009.  Masimo’s third quarter product revenue rose 18.2% to $88.8 million, compared to $75.1 million for the third quarter of 2009.  Revenue from Masimo rainbow products rose 98.7% to $11.9 million in the third quarter, compared to $6.0 million for the third quarter of 2009.  

    Net income for the third quarter was $16.4 million, or $0.27 per diluted share, including $0.01 per diluted share in one-time marketing-related expenses that Masimo had previously planned and announced after receiving $30.1 million in proceeds in the first quarter of 2010 from an antitrust lawsuit against Covidien.  Excluding these one-time expenses, adjusted net income for the third quarter was $16.9 million, or $0.28 per diluted share, compared to net income of $13.1 million, or $0.22 per diluted share, in the third quarter of 2009.  

    During the third quarter, the company shipped approximately 37,500 Masimo SET pulse oximetry and Masimo rainbow SET Pulse CO-Oximetry units, excluding handheld units, up 43.1% compared to approximately 26,200 in the same period last year.  Masimo estimates its worldwide installed base as of October 2, 2010 to be 821,00
    '/>"/>

    SOURCE Masimo Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting
    2. Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010
    3. New Multi-Center Study Finds Clinical Practice Change with Masimo SET Pulse Oximetry Reduces Severe Eye Damage More Than 50% in Premature Newborns
    4. Masimo Noninvasive and Continuous Hemoglobin Receives Market Clearance in Japan
    5. Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System
    6. Masimo to Present at Stifel Nicolaus 2010 Healthcare Conference
    7. Banner Health Converts 23-Hospital System to Masimo rainbow SET Technology
    8. Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery
    9. Frankfurt am Main Emergency Medical Services Makes Masimo Rad-57 Pulse CO-Oximeters Mandatory for All Vehicles
    10. Premier Members to Benefit from Full Line of Market-Leading Masimo rainbow Pulse CO-Oximetry Solutions with New Agreement
    11. St.Vincent Hospital Renews Multi-Year, System-wide Contract for Masimo SET(R) Pulse Oximetry Technology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... PLAINS, N.Y. , July 23, 2014 /PRNewswire-USNewswire/ ... approval of idelalisib to treat patients with relapsed ... small lymphocytic lymphoma (SLL) is a significant advance ... Idelalisib, which goes by the trade name ... a protein that is highly expressed in many ...
    (Date:7/23/2014)... July 23, 2014  Varian Medical Systems (NYSE: ... $1.02 per diluted share in the third quarter of ... about $0.06 per diluted share due to an approximately ... Varian,s existing equity investment in Augmenix, a privately-held company ... totaled $748 million for the third quarter of fiscal ...
    (Date:7/23/2014)... Conn. , July 23, 2014 UBM ... – a new online community and information resource ... better manage and treat their patients with neurological ... coupled with an aging population, necessitates greater access to ... disorders.  Key statistics on neurological conditions include: ...
    Breaking Medicine Technology:The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3
    ... Rochester Medical Implants ( http://www.rmi.us.com ), a contract manufacturer ... it has relocated corporate offices and manufacturing operations to ... the location change, the company will change its name ... The new facility is a modern 33,000-square ...
    ... Calif., Oct. 17, 2011 ChemoCentryx, Inc., today ... trial for CCX168, an orally-administered small molecule for ... (AAV), a disease which can lead to renal ... receptor (C5aR), a potent pro-inflammatory mediator that is ...
    Cached Medicine Technology:Rochester Medical Implants Relocates to New Facility in Noblesville, IN 2ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 2ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 3ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 4
    (Date:7/23/2014)... Lake Worth, FL (PRWEB) July 23, 2014 ... will take place Aug. 10-16, Millennium Treatment Group is ... Substance abuse has existed in society ever since man ... make wine. Substance abuse treatment has existed since shortly ... of recognizing a problem and then developing a way ...
    (Date:7/23/2014)... July 23, 2014 A new study ... power morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally invasive ... throughout a woman’s body, Bernstein Liebhard LLP reports. The ... Journal of the American Medical Association, looked at 36,000 ... at 500 U.S. hospitals from 2006 to 2012. Ninety-nine ...
    (Date:7/23/2014)... Alan Mozes HealthDay Reporter ... servicemen are more likely to have been exposed to some ... new survey suggests. The finding seems to apply solely ... that the finding could be a cause for concern, given ... and/or sexual abuse among the civilian population has been linked ...
    (Date:7/23/2014)... YORK, NY, July 24, 2014) If past experience ... York State are about to get a lot more ... laws already on the books allowing NPs to provide ... to patient care and better relationships with physicians and ... a study from Columbia University School of Nursing, published ...
    (Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
    Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3Health News:New York law offers nurses more recognition, responsibility 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3
    ... has earmarked $74 million to combat the bird flu threat ... was to announce the funding in Busan, Korea, where he ... ,International agencies, like the World Health Organization (WHO), would ... would go on a simulation exercise run by APEC to ...
    ... to the World Health Organization (WHO) experts, concerted ... complete eradication of the five neglected tropical diseases ... // years. , WHO has identified five ... leishmaniasis (kala azar), soil transmitted helminths (STH) and ...
    ... the national nursing shortage by producing more qualified nursing ... Robert W. Woodruff Foundation has awarded // $995,000 to ... support its new doctorate of nursing practice program, the ... ,Thanking the Atlanta-based Woodruff Foundation, a private organization, for ...
    ... by the Italian phrase 'malaria' — or 'bad air' — ... days, scientists know malaria is spread by mosquitos. // And ... the spread of a disease that kills 1 million people ... the situation is bad. The number of deaths are rising, ...
    ... hospital will begin performing open-heart surgeries on patients in ... new unit equipped with the // latest equipment including ... light, automatic operation bed and latest x-ray machines for ... superintendent, IGMC., ,The new unit will be launched ...
    ... movie may induce enough stress to interfere with your ... you sit down to watch a violent or // ... ability. ,David Beversdorf, a neurologist at the State ... and asked them to combine movie viewing with problem-solving ...
    Cached Medicine News:Health News:Concerted Effort Imperative For Elimination Of Tropical Diseases: WHO 2Health News:Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program 2Health News:Malaria Vaccine May Be 10 Years Away 2Health News:Malaria Vaccine May Be 10 Years Away 3
    ... CO2 laser system used in neurophysiology for studying ... the amplitude and/or the duration of the stimulus ... the laser emission in an ongoing manner by ... this laser include the high repeatability of the ...
    ... advanced system for laser therapy available today. The ... fiber handpiece that allows to perform linear scanning ... 20% of the energy reflected by the skin. ... special gel which optimizes the optical coupling between ...
    Smart Chill is a compact cooling system that provides intense localised skin cooling through a comfortable contact handpiece....
    ... Smart 1064 DW with the capability of ... nm) offering increased coagulative and ablative capacities.Smart 1064 ... between two different wavelengths: ordinary 1064 nm (with ... 1320 nm (with powers among 2 and 25 ...
    Medicine Products: